ID: ALA4533219

Max Phase: Preclinical

Molecular Formula: C12H5NNa4O12S4

Molecular Weight: 487.47

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  O=S(=O)([O-])c1cc(S(=O)(=O)[O-])c2[nH]c3c(S(=O)(=O)[O-])cc(S(=O)(=O)[O-])cc3c2c1.[Na+].[Na+].[Na+].[Na+]

Standard InChI:  InChI=1S/C12H9NO12S4.4Na/c14-26(15,16)5-1-7-8-2-6(27(17,18)19)4-10(29(23,24)25)12(8)13-11(7)9(3-5)28(20,21)22;;;;/h1-4,13H,(H,14,15,16)(H,17,18,19)(H,20,21,22)(H,23,24,25);;;;/q;4*+1/p-4

Standard InChI Key:  SRYRVXUPYDAHEP-UHFFFAOYSA-J

Associated Targets(Human)

Dual specificity protein phosphatase 5 23 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 487.47Molecular Weight (Monoisotopic): 486.9008AlogP: 0.31#Rotatable Bonds: 4
Polar Surface Area: 233.27Molecular Species: ACIDHBA: 8HBD: 5
#RO5 Violations: 0HBA (Lipinski): 13HBD (Lipinski): 5#RO5 Violations (Lipinski): 1
CX Acidic pKa: -3.39CX Basic pKa: CX LogP: -0.19CX LogD: -9.69
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.31Np Likeness Score: -0.15

References

1.  (2018)  Small molecule antagonists of dusp5 and methods of use, 

Source